Additionally, the study analyzed the correlation between RBFOX2 and immune cells such as CD8+ T cells, Tregs, tumor-associated macrophages, and NK cells, which are known as immunotherapy related cells (Lin et al., 2020; Xu et al., 2021; Song et al., 2022; Larrayoz et al., 2023). Here, CD8A is linked to neoplasm.